Your browser doesn't support javascript.
loading
Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab.
McIntyre, William F; Oqab, Zardasht; Seaborn, Geoffrey E J; Hopman, Wilma M; Hammad, Nazik; Baranchuk, Adrian.
Affiliation
  • McIntyre WF; Department of Medicine, Queen's University, Kingston, Ontario, Canada; Section of Cardiology, Division of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Oqab Z; Department of Medicine, Queen's University, Kingston, Ontario, Canada; Department of Cardiology, University of Calgary, Calgary, Canada.
  • Seaborn GE; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Hopman WM; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
  • Hammad N; Department of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Baranchuk A; Department of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: barancha@kgh.kari.net.
Int J Cardiol ; 219: 25-6, 2016 Sep 15.
Article in En | MEDLINE | ID: mdl-27257852

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Aldosterone / Cardiotoxins / Bevacizumab / Heart Rate / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cardiol Year: 2016 Document type: Article Affiliation country: Canada Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Aldosterone / Cardiotoxins / Bevacizumab / Heart Rate / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cardiol Year: 2016 Document type: Article Affiliation country: Canada Country of publication: Netherlands